An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and ...
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Palopegteriparatide improved skeletal dynamics and renal ...
Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...
COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND) announced Friday that a new pooled analysis demonstrated sustained improvements in renal function among adults with hypoparathyroidism treated with ...
Results showed eneboparatide compared with placebo met the primary endpoint with statistical significance at 24 weeks. Topline data were announced from a phase 3 trial evaluating eneboparatide in ...
Verywell Health on MSN
What happens to your blood pressure when you take calcium supplements
Medically reviewed by Patricia Mikula, PharmD Key Takeaways Calcium supplements may slightly lower blood pressure.It does this by supporting blood vessel function and by reducing parathyroid hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results